← SynDRA
VERUBECESTAT
SynDRA canonical compound SYN0038031 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | BACE1 |
|---|
| Mechanism of action | beta secretase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BACE1 INHIBITOR
- Beta-secretase 1 inhibitor
- beta secretase inhibitor
Cross-references
Synonyms
- MK-8931
- SCH-900931
- SCH900931
- VERUBECESTAT (MK-8931)
- example 25 (US8940748)
- SCH 900931
- J1I0P6WT7T
- verubecestatum
- RefChem:901821
- DTXCID401478387
- Verubecestat (MK-8931)
- C17H17F2N5O3S
- MFCD28963974
- BDBM143220
- Verubecestat [USAN:INN]
- UNII-J1I0P6WT7T
- VerubecestatFreeBase
- Verubecestat [USAN]
- Verubecestat Free Base
- VERUBECESTAT [INN]
- VERUBECESTAT [JAN]
- Verubecestat; MK-8931
- VERUBECESTAT [WHO-DD]
- GTPL8699
- orb1300146
- Verubecestat (JAN/USAN/INN)
- SCHEMBL10328722
- SCHEMBL17507398
- SCHEMBL29361623
- SCHEMBL30477101
- BDBM47353
- GLXC-10657
- HMS3886D12
- EX-A2003
- LBC77055
- BDBM50580216
- s8564
- 2-(4-Bromobenzylthio)benzo[d]oxazole
Look up VERUBECESTAT in the interactive SynDRA portal →